Mateusz Kaczmarek

April 29, 2026, 6:27 AM EDT. McKesson (MCK) shares hover around $835 after a substantial 343% gain over five years. The stock experienced minor short-term declines, including a 0.9% drop over seven days and is up 1.4% year-to-date. Analysts' Discounted Cash Flow (DCF) models indicate the stock could be undervalued by approximately 45%, with intrinsic value estimated near $1,521 per share. McKesson trades at a price-to-earnings (P/E) ratio of 23.6, slightly below the healthcare sector average of 24.3. The company's steady cash flow and valuation metrics suggest potential investment value despite recent price cooling.